The role of non-coding RNA in lupus nephritis

• Published in: Human cell : official journal of Human Cell Research Society 2023-05, Vol.36 (3), p.923-936
• Main Authors: Liang, Hanzhi, Liu, Qinghua
• Format: Article
• Language: English
• Subjects: Autoimmune diseases; Biomarkers; Biomedical and Life Sciences; Cell Biology; Cell proliferation; Circular RNA; Gynecology; Humans; Life Sciences; Lupus; Lupus Erythematosus, Systemic - genetics; Lupus nephritis; Lupus Nephritis - diagnosis; Lupus Nephritis - genetics; MicroRNAs - genetics; Nephritis; Non-coding RNA; Nucleotides; Oncology; Oxidative stress; Reproductive Medicine; Review Article; RNA, Circular - genetics; RNA, Long Noncoding - genetics; Stem Cells; Surgery; Systemic lupus erythematosus; Therapeutic targets
• ISSN: 1749-0774; 0914-7470; 1749-0774
• DOI: 10.1007/s13577-023-00883-w

Systemic lupus erythematosus (SLE) is a common autoimmune disease with multiple manifestations. The renal implication, also called lupus nephritis (LN) is the most regular type of complication and results in adverse outcomes. Multiple studies revealed the importance of non-coding RNA in diseases, likewise observed in nephropathies, particularly LN. Long-non-coding RNA (lncRNA) is a group of RNA that are more than 200 nucleotides in length. And in circular RNA (circRNA), the head and tail of RNA are connected by a 3′ → 5′ phosphodiester bond. Both two types of non-coding RNA play important roles in LN pathogenesis through the competitive endogenous RNA (ceRNA) effect. LncRNAs and circRNAs can sponge miRNAs and consequently act on downstream signaling pathways, which are capable to influence various aspects of LN, including cell proliferation, inflammation, and oxidative stress. And lncRNAs and circRNAs have the potential to act as biomarkers to diagnose LN and distinguish whether SLE patients with LN or not. In the future, lncRNAs and circRNAs may be accessible therapeutic targets.